These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6740308)

  • 1. Immunotoxins.
    Collier RJ; Kaplan DA
    Sci Am; 1984 Jul; 251(1):56-64. PubMed ID: 6740308
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel method to purify immunotoxins from free antibodies using modified recombinant toxins.
    Dhanabal M; Fryxell DK; Ramakrishnan S
    J Immunol Methods; 1995 Jun; 182(2):165-75. PubMed ID: 7790724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of hybridoma supernatants raised against membrane fractions from breast cancer using an immunodot assay.
    Heinsohn R; Seitz CR; Hollinshead AC; Hyun W; Poschmann A
    Cancer Detect Prev Suppl; 1987; 1():235-9. PubMed ID: 3480053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody internalization after cell surface antigen binding is critical for immunotoxin development.
    Kuo SR; Alfano RW; Frankel AE; Liu JS
    Bioconjug Chem; 2009 Oct; 20(10):1975-82. PubMed ID: 19785403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New solid tumor targets for therapeutic monoclonal antibodies.
    Papkoff J
    Expert Opin Ther Targets; 2007 May; 11(5):585-8. PubMed ID: 17465718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotoxins: selection of cell-surface antigens and their corresponding monoclonal antibodies.
    Bjorn MJ; Villemez CL
    Cancer Treat Res; 1988; 37():255-77. PubMed ID: 2908629
    [No Abstract]   [Full Text] [Related]  

  • 7. Engineering of antibodies for breast cancer therapy: construction of chimeric and humanized versions of the murine monoclonal antibody BrE-3.
    Couto JR; Blank EW; Peterson JA; Kiwan R; Padlan EA; Ceriani RL
    Adv Exp Med Biol; 1994; 353():55-9. PubMed ID: 7985542
    [No Abstract]   [Full Text] [Related]  

  • 8. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybridomas and monoclonal antibodies: applications in oncology.
    Zalcberg JR; McKenzie IF
    Aust N Z J Surg; 1982 Aug; 52(4):431-8. PubMed ID: 7052043
    [No Abstract]   [Full Text] [Related]  

  • 10. Monoclonal antibodies in the diagnosis and treatment of malignant conditions.
    Allum WH; Macdonald F; Fielding JW
    Surg Annu; 1986; 18():41-64. PubMed ID: 2417343
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic potential of monovalent monoclonal antibodies.
    Cobbold SP; Waldmann H
    Nature; 1984 Mar 29-Apr 4; 308(5958):460-2. PubMed ID: 6608694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monoclonal antibodies to the antigens of human HeLa tumor cells].
    Malakhova IV; Khizhniakova TM; Novokhatskiĭ AS
    Tsitologiia; 1986 May; 28(5):537-44. PubMed ID: 3526672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies and the biological approach to cancer.
    Carter PW
    J Biol Response Mod; 1985 Aug; 4(4):325-39. PubMed ID: 4031950
    [No Abstract]   [Full Text] [Related]  

  • 14. Isolation of human monoclonal antibodies binding to B fragment of diphtheria toxin.
    Gupta KC; Agha R; Santos E; Brodeur BR
    Hum Antibodies Hybridomas; 1992 Jan; 3(1):25-31. PubMed ID: 1576320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic applications of monoclonal antibodies to human cancer.
    Borowitz MJ; Stein RB
    Arch Pathol Lab Med; 1984 Feb; 108(2):101-5. PubMed ID: 6546490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
    Ramakrishnan S; Houston LL
    Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Definition of human melanoma-associated cell surface antigens by hybridoma monoclonal antibodies.
    Burk MW; Saxton RE; Mann BD; Morton DL
    Surgery; 1983 Jul; 94(1):84-90. PubMed ID: 6857516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybridoma antibody to breast cancer immune complexes.
    Papsidero LD; Nemoto T; Valenzuela L; Chu TM
    Hybridoma; 1982; 1(3):275-82. PubMed ID: 6765320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of monoclonal antibodies to Sp2/O-Ag 14 myeloma cells.
    Zlotnik H; Miranda MT; Kozek WJ; Borrero GL; Lavergne JA; Díaz AM
    P R Health Sci J; 1988 Apr; 7(1):31-4. PubMed ID: 3375421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface-epitope masking: a strategy for the development of monoclonal antibodies specific for molecules expressed on the cell surface.
    Shen R; Su ZZ; Olsson CA; Goldstein NI; Fisher PB
    J Natl Cancer Inst; 1994 Jan; 86(2):91-8. PubMed ID: 7505832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.